Blog

Small Pharma Announces Appointment of Lyne Fortin as Chair of the Board

Aug 30 • 3 min read

Quick Take: Ms. Fortin has served as a director for the company since April of this year, and will hold the Chair of the Board position until the next annual meeting of shareholders. Small Pharma Inc. (TSXV: DMT), a neuropharmaceutical company focused on psychedelic-assisted therapies, is pleased to announce that Ms. Lyne Fortin has been…

Braxia Scientific Comments on US Class Action

Aug 27 • 2 min read

Quick Take: The complaint alleges that the company and the individual defendants violated ss. 10(b) and 20(a) of the Securities Exchange Act. Braxia Scientific Corp. (CSE: BRAX) (OTC: BRAXF), today reported that it was served with a class action complaint against the Company, its former CEO and president, for the violation of US federal securities laws….

Awakn Life Sciences Initiates the First Ketamine Treatment Study for Gambling Addiction Led by Professor Celia Morgan

Aug 26 • 3 min read

Quick Take: The study will be led by Dr. Celia Morgan, a professor of psychopharmacology at the University of Exeter. Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (Awakn), a biotechnology company developing and delivering psychedelic medicine to better treat Addiction, announced today that it has received ethical committee approval and has initiated…

PharmaDrug Announces Clinical Research Collaboration with The Johns Hopkins University to Evaluate DMT in a Comparative Clinical Study

Aug 26 • 5 min read

Quick Take: The clinical trial agreement will study the acute and enduring psychological and neural effects of DMT. PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) (“PharmaDrug” or the “Company“), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased…

Mycelial Gallery Blends Crypto and Psychedelics to Raise Money For MAPS; Donates $108k

Aug 26 • 2 min read

There’s no denying the crossover between psychedelics and cryptocurrency. The founders of some of the largest public psychedelic companies are deeply involved in the cryptocurrency and blockchain space. This includes: The founder of ATAI Life Sciences (ATAI), Christian Angermayer, who is also a founder of Cryptology Asset Group Michael Novogratz, an early investor in Compass…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538